Fig. 6From: The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomassi-HOTAIR and fenofibrate combined therapy slowed glioma growth. A H&E staining of different groups of U87 intracranial glioma models. Tumor volume was measured every 7 days by in vivo imaging. B Statistical analysis results of the control and combined therapy intracranial glioma groups for every 7 days. The data are shown as the mean ± SD. *, P < 0.05. C Survival curve plots of the control and combined therapy intracranial glioma groups. D Immunohistochemical staining. White bar, 50 μmBack to article page